ODI Pharma

ODI Pharma

Pressreleases, rapporter och nyheter för ODI Pharma

Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2022/2023
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: ODI Pharma AB postpones publication of interim report and annual report until November 24, 2023
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Notice to Annual General Meeting in ODI Pharma AB (publ)
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Kallelse till årsstämma i ODI Pharma AB (publ)
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Kallelse till årsstämma i ODI Pharma AB (publ)
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Reports: ODI Pharma AB: Publication of year-end report for the fiscal year 2022/2023
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: ODI Pharma AB receives loan financing of EUR 350,000
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Reports: ODI Pharma AB: Publication of interim report report Q3 2022/2023
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Reports: ODI Pharma AB: Publication of half-year report 2022/2023
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Reports: ODI Pharma AB: Publication of half-year report 2022/2023
Loading...